Alzheimer’s drug ruling ”a terrible decision”
October 11, 2006Sales and Marketing
Campaigners are stunned at NICE's final decision not to allow Alzheimer's drugs to be prescribed on the NHS in the …
Takeda retains The Remedy for European events
October 6, 2006Medical Communications
Takeda Europe has re-appointed marketing firm The Remedy to run its pan-European and international meetings for 2007.The Remedy, which is …
Amgen to acquire Avidia
October 5, 2006Research and Development, Sales and Marketing
Amgen is to pay $290 million to buy Avidia, a Californian biotech company which is developing innovative new protein-based medicines.Based …
General practice reaps rewards of contract
October 2, 2006GPs and patients are continuing to reap the rewards of the new general practice contract, with doctors hitting targets for …
Novartis’ MS drug shows further promise
October 2, 2006Research and Development
A new treatment for multiple sclerosis currently being developed by Novartis has shown further promise in slowing the progress of …
Transparently beneficial?
October 2, 2006Medical Communications, Sales and Marketing industry relations, key opinion leaders, pharma
The pharma industry is under greater pressure than ever before to adopt an acceptable and ethical way of doing business, …
Pharmacists unhappy with Pfizer’s new UK supply chain
September 29, 2006Manufacturing and Production
Pfizer has announced a radical overhaul of how it distributes its medicines to community pharmacists and dispensing doctors in the …
Novartis submits next generation blood pressure drug
September 29, 2006Sales and Marketing
Next generation hypertension drug Rasilez has been submitted for EU approval.If approved, Rasilez will be the first ever renin inhibitor, …
Two new AstraZeneca laboratories opened in UK
September 29, 2006Research and Development
AstraZeneca has officially opened two major research laboratories in the UK, which it says demonstrates its commitment to R&D in …
GSK scores partial victory over parallel traders
September 29, 2006Manufacturing and Production
GlaxoSmithKline has won a partial but significant victory in a European Union court which could give it and other pharma …
Three innovative medicines win Prix Galien awards
September 27, 2006Sales and Marketing prix galien
Three pharmaceutical products have been awarded prizes at this year’s UK Prix Galien awards, which recognise excellence in pharmaceutical development …
UCB to buy Schwarz Pharma for 4 billion euros
September 26, 2006Sales and Marketing
Belgian pharma company UCB is to buy Germany's Schwarz Pharma for 4.4 billion euros, creating a new mid-sized group with …
Noxafil close to approval for invasive fungal infections
September 25, 2006Sales and Marketing
Schering-Plough's Noxafil is set to gain European approval for patients at high risk of developing invasive fungal infections.These infections can …
GSK gambles on success of new European pricing deal
September 25, 2006Sales and Marketing EU, GSK
GlaxoSmithKline has unveiled a new deal which could break the deadlock over the pricing of medicines in Europe.The groundbreaking agreement …
Gardasil approved in Europe
September 22, 2006Sales and Marketing Gardasil
Sanofi Pasteur MSD's Gardasil has been approved as the first ever vaccine to prevent women developing cervical cancer, which remains …
Specialist pharma company Nycomed buys Altana
September 22, 2006Sales and Marketing Nycomed
Danish speciality pharmaceutical company Nycomed is to acquire pharma company Altana for 4.5 billion euros.Germany's Altana is currently a business …
New diabetes drug Byetta set for European approval
September 22, 2006Sales and Marketing Byetta, diabetes
Lilly and Amylin's new diabetes treatment Byetta is set for European approval following recommendation from medicines regulator the EMEA.Byetta (exenatide) …
Merck to buy Serono for $13 billion
September 22, 2006Sales and Marketing Merck Serono
German pharma company Merck is to acquire Serono for $13.5 billion, creating one of Europes largest bio-pharmaceutical technology companies.The new …
AZ and Schering take novel approach in cancer collaboration
September 22, 2006Research and Development
AstraZeneca and Schering are to co-develop a promising new drug candidate to treat breast cancer, with the two partners taking …
Integrated Huntsworth Health moves into top tier
September 22, 2006Medical Communications
Healthcare communications group Huntsworth has merged its advertising, medical education and PR agencies into a single, fully integrated company, to …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
